69 active trials 26 recruiting 39 Phase 3 32 disease areas 29 changes in 30 days
| Phase 2 | 18 | |
| Phase 2/3 | 5 | |
| Phase 3 | 34 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT05008848 | Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program | Cigarette Smoking-Related Carcinoma | Recruiting | 2026-09-21 |
| NCT05379153 | Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The… | Vaginal Atrophy | Recruiting | 2026-09-03 |
| NCT05677490 | mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced… | Advanced Esophageal Adenocarcinoma | Recruiting | 2026-09-03 |
| NCT03150693 | Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly… | B Acute Lymphoblastic Leukemia | Recruiting | 2026-09-02 |
| NCT05976763 | Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for… | Mantle Cell Lymphoma | Recruiting | 2026-09-02 |
| NCT06661720 | Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab)… | Clear Cell Renal Cell Carcinoma | Recruiting | 2026-09-02 |
| NCT06876714 | ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+… | Anatomic Stage I Breast Cancer AJCC v8 | Recruiting | 2026-09-02 |
| NCT06931340 | Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy… | Castration-Sensitive Prostate Carcinoma | Recruiting | 2026-09-02 |
| NCT07200830 | Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and… | Metastatic Castration-Resistant Prostate Carcinoma | Recruiting | 2026-09-02 |
| NCT07215910 | Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for… | Astrocytoma, IDH-Mutant, Grade 3 | Recruiting | 2026-09-02 |
| NCT07321652 | Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment… | Chronic Lymphocytic Leukemia | Recruiting | 2026-09-02 |
| NCT05812807 | Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a… | Anatomic Stage II Breast Cancer AJCC v8 | Recruiting | 2026-08-05 |
| NCT07000084 | Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone)… | Recurrent Non-Muscle Invasive Bladder Carcinoma | Recruiting | 2026-08-05 |
| NCT06992427 | High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral… | Head and Neck Squamous Cell Carcinoma | Recruiting | 2026-05-11 |
| NCT04379570 | Additional Support Program Via Text Messaging and Telephone-Based Counseling for Breast… | Anatomic Stage I Breast Cancer AJCC v8 | Active, Not Recruiting | 2026-10-01 |
| NCT04989504 | Testing the Application of Mepitel Film During Radiation Therapy to Reduce Radiation… | Breast Carcinoma | Active, Not Recruiting | 2026-09-23 |
| NCT04114981 | Single Fraction Stereotactic Radiosurgery or Three to Five Fraction Stereotactic… | Metastatic Malignant Neoplasm in the Brain | Active, Not Recruiting | 2026-09-17 |
| NCT04340141 | Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable… | Pancreatic Adenosquamous Carcinoma | Active, Not Recruiting | 2026-09-04 |
| NCT02750826 | Breast Cancer WEight Loss Study (BWEL Study) | Breast Ductal Carcinoma In Situ | Active, Not Recruiting | 2026-09-02 |
| NCT06632327 | Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB… | Resectable Lung Non-Small Cell Carcinoma | Active, Not Recruiting | 2026-09-02 |
| NCT01901094 | Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With… | Stage II Breast Cancer | Active, Not Recruiting | 2026-08-31 |
| NCT04939090 | Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced… | Advanced Malignant Solid Neoplasm | Active, Not Recruiting | 2026-07-30 |
| NCT02375204 | Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem… | Germ Cell Tumor | Active, Not Recruiting | 2026-06-16 |
| NCT04457596 | T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High… | Anatomic Stage II Breast Cancer AJCC v8 | Active, Not Recruiting | 2026-06-15 |
| NCT01953588 | Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III… | Estrogen Receptor-positive Breast Cancer | Active, Not Recruiting | 2026-06-05 |
Breast Cancer (18) · Colorectal Cancer (8) · Prostate Cancer (8) · Leukemia (7) · Acute Lymphoblastic Leukemia (ALL) (5) · Bladder Cancer (5) · Lung Cancer (5) · Esophageal Cancer (4) · Gastric Cancer (4) · Pancreatic Cancer (4)